Category:
Prophylactic Biological Products
CAS NO:
1256388-51-8
Standard:
In-house Standards,
A benzimidazole derivative that is used in combination with sofosbuvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection.
Ledipasvir is a direct-acting antiviral agent used in combination therapy for chronic Hepatitis C. Manufactured via advanced chiral synthesis, its molecular formula is C28H19FN6O4 with CAS No. 1078352-67-2.
Strictly contraindicated with amiodarone due to bradycardia risks. Store in sealed containers at controlled room temperature (20°C–25°C) away from moisture and light to maintain stability.